Company Overview
Yosemite is a leading venture capital investment firm established in 2023, with its headquarters in San Francisco, California. The firm is committed to making cancer non-lethal within our lifetime by investing in early-stage companies in the healthcare, medical, and biotechnology sectors. Its focus on digital health and virtual cancer care is demonstrated through its inaugural investment in Maia Oncology. Yosemite collaborates with entities like the American Cancer Society to support pioneering research in oncology.
Key Financial Highlights
- Initial Fundraising: Over $300 million has been raised, surpassing Yosemite's initial fundraising goal to support its strategic investment endeavors.
- Strategic Partnerships: The firm has secured a $13.2 million partnership with the American Cancer Society to drive forward oncology advancements.
Leadership
Under the leadership of Reed Jobs, Yosemite combines venture capital with strategic grant allocations to enhance its impact on cancer treatment research. Reed Jobs, previously the Managing Director of Health at Emerson Collective, is noted for utilizing his familial legacy to establish a formidable presence in the biotech investment landscape.
Key Team Members:
- Dan McHugh: An investor and former Emerson Collective stakeholder, offering significant industry insight and leadership in cancer-focused initiatives.
- Matt Bettonville: An expert investor specializing in emergent oncology innovations, guiding the firm's strategic investments.
Employee Structure and Growth
Yosemite employs 35 individuals and has witnessed a dramatic 483% growth in its workforce over the past year. Key members of the team include:
- Renee Jay: Chief of Staff
- John Ainslie: Analyst
- Abel Negussie: Analyst
- Kenna Thompson: Executive Assistant
- Emily Kian: Executive Assistant to the COO
Strategic Vision
Yosemite focuses on discovering and supporting cancer care breakthroughs, implementing a strategic mix of venture capital and grants to propel significant oncology research efforts. This approach establishes the firm as an innovative leader in oncology financing, adept at identifying and fostering transformative healthcare ventures.
Industry Positioning
Operating within the Venture Capital and Private Equity Principals industry, Yosemite distinguishes itself through strategic partnerships and funding efforts aimed at cancer treatment progressions. The firm leverages significant collaborations to support projects at various stages of oncology development.
Competitor Landscape
Yosemite's competitive environment includes several notable firms:
- Employee Stock Option Fund (ESO Fund): Estimated revenue of $3.5 million with 18 employees, focusing on employee stock options.
- Sway Ventures: Generates $7.5 million with 57 employees, specializing in fintech, real estate, retail, and supply chain sectors.
- Norland: A high-tech entity concentrating on innovation in life sciences, renowned for its contributions to national projects.
- Dell Technologies: A global player in computer technology, emphasizing robust digital solutions.
Contact Information
- Website: [yosemite.co](https://yosemite.co/)
- Email: info@yosemite.co
- Address: 901 Battery St, San Francisco, CA 94111
Yosemite's dedication to transforming healthcare through strategic investments is evidenced by its substantial growth and strategic partnerships, reinforcing its status as a key influencer in the oncology treatment sector.
